The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CLOVER HEALTH INVESTMENTS CO COM CL A 18914F103 748 210,639 SH   SOLE   210,639 0 0
DAY ONE BIOPHARMACEUTICALS I COM 23954D109 329 33,125 SH   SOLE   33,125 0 0
DYNE THERAPEUTICS INC COM 26818M108 336 34,887 SH   SOLE   34,887 0 0
ISHARES TR RUS 2000 VAL ETF 464287630 48,880 302,850 SH   SOLE   302,850 0 0
MONDAY COM LTD SHS M7S64H106 265 1,676 SH   SOLE   1,676 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107 464 34,100 SH   SOLE   34,100 0 0
SELECT SECTOR SPDR TR ENERGY 81369Y506 109,290 1,429,749 SH   SOLE   1,429,749 0 0
VANGUARD INTL EQUITY INDEX F TT WRLD ST ETF 922042742 3,173 31,329 SH   SOLE   31,329 0 0